In mTOR-driven HCC models, tumor cells also enhance arginine uptake while reducing its conversion to polyamines, thus promoting oncogenic metabolism through the arginine-binding protein RNA binding motif protein 39 (RBM39). This evidence concerns the gene MTOR and hepatocellular carcinoma.